Blog

Novo launches Saxenda in US, sees more launches in 2015

Novo Nordisk has launched its Saxenda obesity drug in the United States, it said on Wednesday, a long-awaited milestone that will provide a new revenue stream for the Danish drugmaker. Sydbank analyst Soren Lontoft Hansen said the price was as expected because it has the same active ingredient as Novo’s Victoza- a diabetes drug used to treat obesity directly.

EU proposes GM opt-out for members, angering pro and anti-GM camps

By Philip Blenkinsop BRUSSELS (Reuters) – The European Commission proposed on Wednesday a new law allowing individual EU countries to restrict or prohibit imported genetically modified crops even if they have been approved by the bloc as a whole. The proposal covering GM crops in human food and animal feed upset trading partners, notably the United States, which wants Europe to open its doors fully to U.S. GM crops as

Balding German man refused free wig

Baldness among older men is not a medical condition requiring health insurance companies to cover a toupee or wig, a German federal court ruled Wednesday, turning down a 76-year-old man’s bid for false hair. The man from the western town of Contwig, who has suffered from a lack of scalp hair as well as eyebrows and eyelashes since 1983, took his case against his insurance company to the Federal Social